S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
RCEL · Avita Medical, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
AVITA Medical Inc (RCEL)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$15.29
+1.53
(+11.16%)
● At close: October 21 at 4:00:00 PM EDT
$15.29
+0.00
(+0.00%)
Overnight:
11:35:01 PM EDT
DAY'S RANGE
$15.29
$14.09
$15.60
52-WEEK RANGE
$15.29
$3.22
$13.73
What's happening
- RCEL is up 11.16% today, trading at $15.29. — Live quote
- It's trading within 3% of its 52-week high ($13.73). (Finnhub fundamentals)
- Volume today (50,267) is well below its 3-month average of 421,310. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.25 actual vs. $-0.29 estimated (+14.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 5
Hold 1
Sell 0
Strong sell 1
Aggregate ratings for 2026-09-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
RCEL
+277.97%
vs S&P 500
+266.04%
1-YEAR RETURN
RCEL
+142.38%
vs S&P 500
+126.85%
6-MONTH RETURN
RCEL
+132.86%
3-MONTH RETURN
RCEL
+155.69%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.25
Est. $-0.29
BEAT +14.5%
2026-04-26 (Q1 2026)
$-0.35
Est. $-0.29
MISS -22.5%
2026-01-26 (Q4 2025)
$-0.38
Est. $-0.34
MISS -10.9%
2025-10-26 (Q3 2025)
$-0.46
Est. $-0.29
MISS -58.8%
Valuation Measures & Ratios
Enterprise Value4$440.8M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)5.33
Price / Book774.59
EV4 / Revenue5.83
EV4 / EBITDA—
Profit Margin-56.96%
Operating Margin-46.57%
Return on Equity (ROE8)-337.90%
Return on Assets (ROA9)-78.53%
Avg Volume (3M)421,310
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $126.6M | $112.2M | $146.9M | $137.7M | $212.6M |
| P/E | -3.06 | -2.36 | -2.76 | -2.49 | -3.32 |
| Price/Sales | 1.66 | 1.53 | 2.00 | 1.92 | 3.30 |
| Price/Book | -4.55 | -4.84 | -22.04 | -10.68 | -46.51 |
| EV/Revenue | 2.15 | 2.05 | 2.37 | 2.34 | 3.72 |
| EV/EBITDA | -4.88 | -3.88 | -3.96 | — | — |
| ROE | 148.65% | 205.37% | 797.64% | 429.55% | 1402.65% |
| ROA | -86.61% | -92.30% | -83.43% | -95.26% | -92.18% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,887,981
Change from Prior Settlement+0.08%
% of Float—
Days to Cover (Short Ratio)9.20
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 17.8% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +142.4%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -57.0%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-08-11; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on RCEL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.7M | $19.3M | $17.1M | $18.4M | $18.5M | $19.5M | $15.2M | $11.1M |
| Gross profit | $17.8M | $15.7M | $13.9M | $14.9M | $15.7M | $16.4M | $13.1M | $9.6M |
| Operating income | -$6.9M | -$8.8M | -$9.2M | -$11.1M | -$11.8M | -$13.8M | -$15.6M | -$17.2M |
| Net income | -$7.7M | -$10.6M | -$13.2M | -$9.9M | -$13.9M | -$16.2M | -$15.4M | -$18.7M |
| EPS (diluted) | $-0.25 | $-0.35 | $-0.46 | $-0.38 | $-0.53 | $-0.62 | $-0.60 | $-0.73 |
| EPS (basic) | $-0.25 | $-0.35 | $-0.46 | $-0.38 | $-0.53 | $-0.62 | $-0.60 | $-0.73 |
| Operating margin | -$32 | -$46 | -$54 | -$61 | -$64 | -$71 | -$103 | -$155 |
| Net margin | -$35 | -$55 | -$77 | -$54 | -$75 | -$83 | -$101 | -$168 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $47.8M | $51.5M | $56.4M | $63.7M | $58.1M | $69.6M | $79.7M | $81.1M |
| Total liabilities | $75.6M | $74.7M | $73.0M | $70.4M | $71.0M | $74.1M | $75.0M | $68.6M |
| Stockholders' equity | -$27.8M | -$23.2M | -$16.6M | -$6.7M | -$12.9M | -$4.6M | $4.5M | $12.2M |
| Total current assets | $28.4M | $31.6M | $35.5M | $41.4M | $36.3M | $48.0M | $57.0M | $63.9M |
| Total current liabilities | $68.7M | $66.7M | $62.7M | $61.8M | $62.6M | $23.0M | $20.2M | $17.1M |
| Cash & equivalents | $9.1M | $8.3M | $10.2M | $15.4M | $12.2M | $14.9M | $14.1M | $18.6M |
| Marketable securities (current) | $2.0M | $6.0M | $7.9M | $7.9M | $3.5M | $10.9M | $21.8M | $25.8M |
| Accounts receivable | $9.9M | $9.9M | $9.1M | $9.0M | $11.3M | $9.1M | $11.8M | $10.3M |
| Inventory | $5.3M | $6.1M | $6.9M | $7.2M | $7.5M | $8.4M | $7.3M | $6.2M |
| Other current assets | — | — | — | — | — | — | — | — |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $7.7M | $8.2M | $8.6M | $9.9M | $9.7M | $9.9M | $10.0M | $9.2M |
| Intangible assets | $5.2M | $5.4M | $5.6M | $5.2M | $5.3M | $5.4M | $5.6M | $590.0K |
| Other non-current assets | $593.0K | $534.0K | $612.0K | $1.1M | $839.0K | $287.0K | $546.0K | $546.0K |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | $46.7M | $46.1M | $43.0M | $42.4M | — | — | $0 | — |
| Other current liabilities | $3.3M | $2.2M | $2.6M | $2.1M | $1.8M | $2.4M | $1.3M | $1.3M |
| Long-term debt | — | — | $0 | $0 | $42.2M | $41.5M | $42.2M | $42.5M |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K |
| Retained earnings | -$426.7M | -$419.0M | -$408.4M | -$396.8M | -$383.6M | -$373.7M | -$359.8M | -$348.2M |
| Accumulated other comprehensive income (loss) | -$82.0K | $648.0K | -$1.4M | -$1.4M | -$2.1M | -$413.0K | -$1.9M | -$2.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.5M | -$10.1M | -$5.4M | -$5.2M | -$10.2M | -$10.3M | -$8.0M | -$7.2M |
| Investing cash flow | $3.9M | $2.0M | $11.0K | -$5.3M | $7.0M | $10.8M | $2.5M | $7.4M |
| Financing cash flow | $437.0K | $6.1M | $248.0K | $13.8M | $559.0K | $363.0K | $1.0M | $1.0M |
| Free cash flow | -$3.6M | -$10.1M | -$4.8M | -$6.2M | -$10.8M | -$10.5M | -$9.7M | -$11.0M |
| Capital expenditures | $108.0K | $19.0K | -$674.0K | $934.0K | $524.0K | $221.0K | $1.6M | $3.8M |
| Depreciation & amortization | $605.0K | $627.0K | $700.0K | $574.0K | $552.0K | $521.0K | $409.0K | $310.0K |
| Share-based compensation | $2.0M | $1.1M | $1.4M | $2.8M | $2.7M | $2.7M | $2.8M | $4.1M |
| Change in inventory | -$765.0K | -$752.0K | -$198.0K | -$144.0K | -$629.0K | $1.4M | $1.1M | -$306.0K |
| Purchases of investments | $0 | $3.9M | $2.0M | $7.9M | $3.5M | — | $5.9M | $12.8M |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jun '21 |
|---|---|---|---|---|---|
| Revenue | $71.6M | $64.3M | $50.1M | $34.4M | $29.2M |
| Gross profit | $58.8M | $55.2M | $42.4M | $28.4M | $23.3M |
| Operating income | -$42.5M | -$56.6M | -$42.7M | -$27.5M | -$26.5M |
| Net income | -$48.6M | -$61.8M | -$35.4M | -$26.7M | -$26.6M |
| EPS (diluted) | $-1.74 | $-2.39 | $-1.40 | $1.07 | $1.17 |
| EPS (basic) | $-1.74 | $-2.39 | $-1.40 | $1.07 | $1.17 |
| Operating margin | -$59 | -$88 | -$85 | -$80 | -$91 |
| Net margin | -$68 | -$96 | -$71 | -$77 | -$91 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $56.4M | $79.7M | $111.6M | $98.3M | $116.0M |
| Total liabilities | $73.0M | $75.0M | $61.9M | $13.0M | $11.4M |
| Stockholders' equity | -$16.6M | $4.5M | $49.1M | $84.7M | $104.6M |
| Total current assets | $35.5M | $57.0M | $104.0M | $87.5M | $92.1M |
| Total current liabilities | $62.7M | $20.2M | $13.2M | $10.7M | $9.1M |
| Cash & equivalents | $10.2M | $14.1M | $22.1M | $18.2M | $55.5M |
| Marketable securities (current) | $7.9M | $21.8M | $66.9M | $61.2M | $29.6M |
| Accounts receivable | $9.1M | $11.8M | $7.7M | $3.5M | $3.1M |
| Inventory | $6.9M | $7.3M | $5.6M | $2.1M | $2.1M |
| Other current assets | — | — | $18.0K | $127.0K | $15.0K |
| Marketable securities (non-current) | — | — | — | $6.9M | $19.7M |
| Property, plant & equipment | $8.6M | $10.0M | $1.9M | $1.2M | $1.3M |
| Intangible assets | $5.6M | $5.6M | $487.0K | $465.0K | $443.0K |
| Other non-current assets | $612.0K | $546.0K | $355.0K | $122.0K | $638.0K |
| Short-term debt | $43.0M | $0 | — | — | — |
| Other current liabilities | $2.6M | $1.3M | $1.3M | $990.0K | $1.1M |
| Long-term debt | $0 | $42.2M | $39.8M | — | — |
| Other non-current liabilities | — | — | — | — | $113.0K |
| Common stock & paid-in capital | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K |
| Retained earnings | -$408.4M | -$359.8M | -$298.0M | -$262.6M | -$235.9M |
| Accumulated other comprehensive income (loss) | -$1.4M | -$1.9M | -$1.9M | $7.6M | $8.1M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jun '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$31.2M | -$48.9M | -$38.0M | -$19.1M | -$25.9M |
| Investing cash flow | $12.5M | $37.4M | $1.6M | -$19.3M | -$1.2M |
| Financing cash flow | $14.9M | $3.5M | $40.4M | $900.0K | $64.0M |
| Free cash flow | -$32.2M | -$58.1M | -$39.4M | -$19.5M | -$26.8M |
| Capital expenditures | $1.0M | $9.2M | $1.4M | $452.0K | $894.0K |
| Depreciation & amortization | $2.3M | $1.1M | $632.0K | $568.0K | $715.0K |
| Share-based compensation | $9.5M | $13.5M | $8.4M | $7.0M | $5.7M |
| Change in inventory | $468.0K | $2.2M | $3.7M | $371.0K | $745.0K |
| Purchases of investments | $13.3M | $24.5M | $78.8M | $74.4M | — |
| Sales/maturities of investments | — | — | $2.4M | — | — |
| Debt issued | — | — | $38.8M | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding RCEL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-11 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-10 | 4 | 2026-06-09 | View on SEC.gov → |
| 2026-06-09 | 4 | 2026-06-09 | View on SEC.gov → |
| 2026-06-08 | 8-K | 2026-06-05 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-03 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-03 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-03 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-03 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-03 | View on SEC.gov → |
Recent news
Headlines about RCEL (Avita Medical, Inc.). Links open the publisher — we don’t host full articles.
-
What Is Driving AVITA Medical (ASX:AVH) Stock Up 8.5% Today?
Kalkine · 2026-10-22 -
RCEL Nov 2026 20.000 call (RCEL261120C00020000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
RCEL Nov 2026 20.000 call (RCEL261120C00020000) interactive stock chart
Yahoo Finance UK · 2026-10-21 -
Avita Medical Q3FY26 Results: Earnings call set for November 5
scanx.trade · 2026-10-20 -
AVITA Medical to Announce Third Quarter 2026 Financial Results
Yahoo · 2026-10-20 -
A live call on AVITA Medical’s third-quarter results is set for Nov. 5 at 1:30 p.m. Pacific.
Stock Titan · 2026-10-20 -
What Comes Next For AVITA Medical After A 276% Gain
Simply Wall Street · 2026-10-19 -
BTIG raises target for Avita Medical stock from USD 11.00 to USD 15.00 - ad-hoc-news.de
ad-hoc-news.de · 2026-10-18
No headlines in this category right now — try “All”.